Sunderkotter CH, Zelger B, Chen KR, Requena L, Piette W, Carlson JA, et al. Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheumatol. 2018;70(2):171–84.

Article  PubMed  Google Scholar 

Micheletti RG. Cutaneous small vessel vasculitis: a practical guide to diagnosis and management. Am J Clin Dermatol. 2023;24(1):89–95.

Article  PubMed  Google Scholar 

Micheletti RG, Chiesa Fuxench Z, Craven A, Watts RA, Luqmani RA, Merkel PA, et al. Cutaneous manifestations of antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol. 2020;72(10):1741–7.

Article  CAS  PubMed  Google Scholar 

Koster MJ, Warrington KJ. ACR and EULAR bring AAV classification into the twenty-first century. Nat Rev Rheumatol. 2022;18(6):309–10.

Article  CAS  PubMed  Google Scholar 

Piette WW. The differential diagnosis of purpura from a morphologic perspective. Adv Dermatol. 1994;9:3–23.

CAS  PubMed  Google Scholar 

Georgesen C, Fox LP, Harp J. Retiform purpura: a diagnostic approach. J Am Acad Dermatol. 2020;82(4):783–96.

Article  PubMed  Google Scholar 

Pagnoux C, Seror R, Henegar C, Mahr A, Cohen P, Le Guern V, et al. Clinical features and outcomes in 348 patients with polyarteritis nodosa: a systematic retrospective study of patients diagnosed between 1963 and 2005 and entered into the french vasculitis study group database. Arthritis Rheum. 2010;62(2):616–26.

Article  PubMed  Google Scholar 

Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. American college of rheumatology/european alliance of associations for rheumatology classification criteria for microscopic polyangiitis. Ann Rheum Dis. 2022;81(3):321–6.

Article  PubMed  Google Scholar 

Bettuzzi T, Jachiet M, Sbidian E, Frumholtz L, Cordoliani F, Mouthon L, et al. Efficacy and safety of treatments in cutaneous polyarteritis nodosa: A French observational retrospective study. J Am Acad Dermatol. 2022;86(5):1035–41.

Article  CAS  PubMed  Google Scholar 

Stewart M, Lo A, Shojania K, Au S, Seidman MA, Dutz JP, et al. Cutaneous polyarteritis nodosa diagnosis and treatment: A retrospective case series. J Am Acad Dermatol. 2022;87(6):1370–3.

Article  PubMed  Google Scholar 

Kelly RI, Wee E, Balta S, Williams RA. Lymphocytic thrombophilic arteritis and cutaneous polyarteritis nodosa: Clinicopathologic comparison with blinded histologic assessment. J Am Acad Dermatol. 2020;83(2):501–8.

Article  PubMed  Google Scholar 

Manduca S, Martin, MR; Martins, K; Femia, A. Clinical Characteristics of Polyarteritis Nodosa. RDS; Washington, DC2024.

Elkon KB, Hughes GR, Catovsky D, Clauvel JP, Dumont J, Seligmann M, et al. Hairy-cell leukaemia with polyarteritis nodosa. Lancet. 1979;2(8137):280–2.

Article  CAS  PubMed  Google Scholar 

Hasler P, Kistler H, Gerber H. Vasculitides in hairy cell leukemia. Semin Arthritis Rheum. 1995;25(2):134–42.

Article  CAS  PubMed  Google Scholar 

Roupie AL, Guedon A, Terrier B, Lahuna C, Jachiet V, Regent A, et al. Vasculitis associated with myelodysplastic syndrome and chronic myelomonocytic leukemia: French multicenter case-control study. Semin Arthritis Rheum. 2020;50(5):879–84.

Article  CAS  PubMed  Google Scholar 

Beck DB, Ferrada MA, Sikora KA, Ombrello AK, Collins JC, Pei W, et al. Somatic mutations in UBA1 and severe Adult-Onset autoinflammatory disease. N Engl J Med. 2020;383(27):2628–38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Daoud MS, Hutton KP, Gibson LE. Cutaneous periarteritis nodosa: a clinicopathological study of 79 cases. Br J Dermatol. 1997;136(5):706–13.

Article  CAS  PubMed  Google Scholar 

Zhou Q, Yang D, Ombrello AK, Zavialov AV, Toro C, Zavialov AV, et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med. 2014;370(10):911–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barron KS, Aksentijevich I, Deuitch NT, Stone DL, Hoffmann P, Videgar-Laird R, et al. The spectrum of the deficiency of adenosine deaminase 2: an observational analysis of a 60 patient cohort. Front Immunol. 2021;12:811473.

Article  CAS  PubMed  Google Scholar 

Wolff L, Horisberger A, Moi L, Karampetsou MP, Comte D. Polyarteritis Nodosa: Old Disease, New Etiologies. Int J Mol Sci. 2023;24(23):16668.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanaka R, Tanese K, Ito Y, Takeuchi S, Morimoto A, Sujino K, et al. Clinical and laboratory findings characterizing the need for systemic corticosteroids and nonsteroidal systemic therapies, and the predicted outcomes in cutaneous polyarteritis nodosa: A single-centre retrospective analysis. Clin Exp Dermatol. 2024;49(11):1338–46. https://doi.org/10.1093/ced/llae143.

Munera-Campos M, Bielsa I, Martinez-Morillo M, Aparicio G, Olive A, Ferrandiz C. Manifestations, clinical course and prognostic markers in cutaneous polyarteritis nodosa. J Dtsch Dermatol Ges. 2020;18(11):1250–9.

Article  PubMed  Google Scholar 

Zoshima T, Matsumura M, Suzuki Y, Kakuchi Y, Mizushima I, Fujii H, et al. A case of refractory cutaneous polyarteritis nodosa in a patient with hepatitis B carrier status successfully treated with tumor necrosis factor alpha blockade. Mod Rheumatol. 2013;23(5):1029–33.

Article  PubMed  Google Scholar 

Kawakami T, Soma Y. Use of warfarin therapy at a target international normalized ratio of 3.0 for cutaneous polyarteritis nodosa. J Am Acad Dermatol. 2010;63(4):602–6.

Article  PubMed  Google Scholar 

Kronbichler A, Bajema IM, Bruchfeld A, MastroianniKirsztajn G, Stone JH. Diagnosis and management of ANCA-associated vasculitis. Lancet. 2024;403(10427):683–98.

Article  CAS  PubMed  Google Scholar 

Yaseen K, Nevares A, Tamaki H. A Spotlight on Drug-Induced Vasculitis. Curr Rheumatol Rep. 2022;24(11):323–36.

Article  PubMed  Google Scholar 

Unizony S, Villarreal M, Miloslavsky EM, Lu N, Merkel PA, Spiera R, et al. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Ann Rheum Dis. 2016;75(6):1166–9.

Article  CAS  PubMed  Google Scholar 

Suppiah R, Robson JC, Grayson PC, Ponte C, Craven A, Khalid S, et al. American college of rheumatology/european alliance of associations for rheumatology classification criteria for microscopic polyangiitis. Arthritis Rheumatol. 2022;74(3):400–6.

Article  CAS  PubMed  Google Scholar 

Grayson PC, Ponte C, Suppiah R, Robson JC, Craven A, Judge A, et al. American college of rheumatology/european alliance of associations for rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Arthritis Rheumatol. 2022;74(3):386–92.

Article  CAS  PubMed  Google Scholar 

Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, Judge A, et al. American college of rheumatology/european alliance of associations for rheumatology classification criteria for granulomatosis with polyangiitis. Arthritis Rheumatol. 2022;74(3):393–9.

Article  CAS  PubMed  Google Scholar 

Fauci AS, Wolff SM, Johnson JS. Effect of cyclophosphamide upon the immune response in Wegener’s granulomatosis. N Engl J Med. 1971;285(27):1493–6.

Article  CAS  PubMed  Google Scholar 

Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jayne DRW, Merkel PA, Schall TJ, Bekker P, Group AS. Avacopan for the treatment of ANCA-Associated Vasculitis. N Engl J Med. 2021;384(7):599-609

Kamiya S, Koizumi H, Suzuki Y, Imai S, Yamashita Y, Ogawa-Momohara M, et al. Cutaneous manifestations of microscopic polyangiitis successfully controlled with avacopan alone. J Dermatol. 2023;50(7):e206–7.

Article  PubMed